Sumitomo Chemical India Reports Robust Q1 FY26 Performance with 26% Revenue Growth
Sumitomo Chemical India Ltd (SCIL) has reported robust financial results for Q1 FY2025-26. Revenue increased by 26% year-over-year to ₹10.60 billion, while consolidated net profit grew by 42% to ₹1.80 billion. EBITDA expanded to ₹2.20 billion, up from ₹1.61 billion, with the EBITDA margin improving to 20.74% from 19.20%. The company's Board of Directors approved these unaudited financial statements on August 4, 2025, following a review by the Audit Committee.

*this image is generated using AI for illustrative purposes only.
Sumitomo Chemical India Ltd (SCIL) has reported a strong financial performance for the first quarter of the fiscal year 2025-26, with significant growth in revenue and profitability.
Financial Highlights
- Revenue increased by 26% year-over-year to ₹10.60 billion
- Consolidated net profit grew by 42% to ₹1.80 billion
- EBITDA expanded to ₹2.20 billion, up from ₹1.61 billion
- EBITDA margin improved to 20.74% from 19.20%
Quarterly Performance Analysis
Sumitomo Chemical India demonstrated robust growth in the quarter ended June 30, 2025. The company's revenue saw a substantial increase of 26%, rising to ₹10.60 billion from ₹8.40 billion in the same quarter of the previous year. This significant top-line growth reflects strong demand for the company's products and effective market strategies.
The company's profitability showed even more impressive gains. Consolidated net profit surged by 42%, reaching ₹1.80 billion compared to ₹1.27 billion in the corresponding period last year. This substantial bottom-line growth outpaced the revenue increase, indicating improved operational efficiency and cost management.
Operational Efficiency
SCIL's operational performance also showed marked improvement. The company's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) expanded to ₹2.20 billion from ₹1.61 billion year-over-year, representing a growth of approximately 36.65%.
Notably, the EBITDA margin improved to 20.74% from 19.20% in the same quarter last year. This 154 basis point increase in EBITDA margin suggests that Sumitomo Chemical India has successfully enhanced its operational efficiency alongside its revenue growth, potentially through better cost control measures and improved productivity.
Corporate Governance
As per the LODR (Listing Obligations and Disclosure Requirements) data, Sumitomo Chemical India's Board of Directors met on August 4, 2025, to approve the unaudited financial statements for the quarter ended June 30, 2025. The meeting, which commenced at 12:01 PM and concluded at 12:35 PM, followed a review by the company's Audit Committee earlier in the day, demonstrating the company's commitment to regulatory compliance and transparent financial reporting.
Conclusion
Sumitomo Chemical India's Q1 FY26 results showcase a company on a strong growth trajectory, with impressive gains in both revenue and profitability. The improved EBITDA margin highlights the company's ability to grow efficiently, potentially positioning it well for continued success in the coming quarters. Investors and market observers will likely keep a close watch on SCIL's performance in the subsequent quarters to see if this growth momentum can be sustained.
Historical Stock Returns for Sumitomo Chemical
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
+0.85% | +9.60% | +18.65% | +21.35% | +28.89% | +127.51% |